Guardian Pharmacy Services (GRDN) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Guardian Pharmacy Services (GRDN) is Moderate Underperform.

The composite score behind that read is -0.27, weighing +0.07 of bullish evidence against -0.31 bearish.

Guardian Pharmacy Services last closed at $42.10, -0.66% on the session.

Against the IVW growth benchmark the position is -1.58% over the forecast window.

The read is built from 11 underlying insights — 1 bullish and 10 bearish.

Agreement across those insights is 91%.

7 graded predictions for GRDN so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Guardian Pharmacy Services in the 19th percentile on valuation and the 88th percentile on return on equity, where 100 is best.

Guardian Pharmacy Services is classified under Health Care / Health Care Providers & Services, with a market capitalisation of $2.68B.

StockMap tracks Guardian Pharmacy Services as the 33rd largest of the 72 companies it covers in the Health Care Providers & Services industry, part of the Health Care sector.

Across that group the current two-week reads are 48 Neutral, 23 Moderate Underperform and 1 Moderate Outperform.

On that composite Guardian Pharmacy Services ranks 59th of 72 in the group, against a group median of -0.13.